Related Experiment Video
Updated: Apr 4, 2026

08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
14.8K
Conventional and robust norming in identifying preclinical dementia
Ellen Grober1, Wenzhu Mowrey2, Mindy Katz1
1a Department of Neurology and the Einstein Aging Study , Albert Einstein College of Medicine and Montefiore Medical Center , Bronx , NY , USA.
Journal of Clinical and Experimental Neuropsychology
|September 2, 2015
Summary
Robust norming procedures improve the detection of preclinical dementia using memory tests. This method enhances sensitivity in identifying individuals who may develop dementia over time.
Area of Science:
- Neuroscience
- Gerontology
- Cognitive Psychology
Background:
- Early detection of preclinical dementia is crucial for timely intervention.
- Memory tests are vital tools in assessing cognitive decline in older adults.
- Normative data are essential for interpreting test scores accurately.
Purpose of the Study:
- To compare four norming approaches for two memory tests in older adults.
- To evaluate the effectiveness of these approaches in detecting preclinical dementia.
- To determine the optimal norming strategy for identifying early cognitive impairment.
Main Methods:
- Participants aged over 70 from the Einstein Aging Study were followed for 5 years.
- Two norming samples were derived: conventional and robust (excluding dementia cases).
- The picture version of the Free and Cued Selective Reminding Test with Immediate Recall (pFCSRT+IR) and Logical Memory (LM) tests were used.
Main Results:
- The robust normative sample yielded higher cut-scores and improved sensitivity for detecting preclinical dementia compared to the conventional sample.
- This improvement in detection sensitivity persisted regardless of age and education adjustments.
- The pFCSRT+IR demonstrated higher sensitivity than the LM test in identifying incident dementia cases.
Conclusions:
- Robust norming procedures enhance the accuracy of detecting preclinical dementia using both pFCSRT+IR and LM tests.
- These findings underscore the importance of employing rigorous norming strategies in cognitive assessments for older adults.
- The study provides evidence for improved diagnostic capabilities in identifying individuals at risk for dementia.
Keywords:
Free and Cued Selective Reminding TestIncident dementiaLogical memoryMemoryMild cognitive impairmentPreclinical dementiaRobust and conventional normsMore Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Dementia
709
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
709
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Diagnostic and Statistical Manual of Mental Disorders (DSM)
1.7K
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
1.7K

